A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

Objective: To evaluate the safety and efficacy of an enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule, after 1, 3, and 6 months. Methods: This was a randomised, placebo controlled, double blind, escalating dose multicentre study in 40 patients with mild to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: van Deventer, S J H, Tami, J A, Wedel, M K
Materialtyp: Artigo
Språk:Inglês
Publicerad: Copyright 2004 by Gut 2004
Ämnen:
Inflammatory Bowel Disease
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774281/
https://ncbi.nlm.nih.gov/pubmed/15479686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.036160
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk